Innrise Biotech Private Limited
About Innrise Biotech Private Limited
Data last updated:
Innrise Biotech Private Limited is a private limited company based in Ambala, Haryana, India. It was incorporated on 11 April 2023.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U46497HR2023PTC110642. Its GSTIN is 06AAHCI0704M1ZN (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Rashmeet Kaur and Sarabjeet Singh.
Its last annual general meeting (AGM) was held on 30 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 99/3 & 99/4 Sethi Enclave Dhulkote, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.07 Lakh. For the same year it recorded a net profit of ₹2,373 (net margin 1.1%) and EBITDA of ₹4,880 (EBITDA margin 2.4%).
Company details
Contact details
Innrise Biotech Private Limited's registered office is in Ambala, Haryana.
- Registered AddressPlot No. 99/3 & 99/4 Sethi Enclave Dhulkote, Ambala, Haryana, India – 134003
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Innrise Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Innrise Biotech Private Limited, buy the company report.
Financials of Innrise Biotech Private Limited
FY 2024 filings availableInnrise Biotech Private Limited reported revenue of ₹2.07 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹4,880 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹2,373 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 2.4% |
| Net Profit Margin | 1.1% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Innrise Biotech Private Limited, buy the company report.
Board of directors of Innrise Biotech Private Limited
Innrise Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmeet Kaur | Director | 11 Apr 2023 | 3 Years 6 Months | Current |
| Sarabjeet Singh | Director | 11 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Innrise Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lay Healthcare Private Limited | ₹2.08 Lakh (FY 2019) | Kota, Rajasthan, India | ||||
| Yeager Pharmaceuticals Private Limited | ₹2.08 Lakh (FY 2025) | -76.0% | Solan, Himachal Pradesh, India | |||
| Wic-Chem Private Limited | ₹2.07 Lakh (FY 2025) | -88.0% | Uttar Pradesh, India | |||
| Ravi Ayurved Bhawan Private Limited | ₹2.07 Lakh (FY 2022) | 164.0% | Chandi, Bihar, India | |||
| Grainery Bio Science Private Limited | ₹2.07 Lakh (FY 2025) | -87.0% | Sirsa, Haryana, India | |||
| Innrise Biotech Private Limitedthis company | ₹2.07 Lakh (FY 2024) | ₹2,373 | 1.1% | Ambala, Haryana, India | ||
| Calisto Developers Private Limited | ₹2.06 Lakh (FY 2024) | -99.0% | Jadcherla, Telangana, India | |||
| Kian Chemicals Limited | ₹2.06 Lakh (FY 2025) | 188.0% | Rajasthan, India | |||
| Vivalyf Innovations Private Limited | ₹2.06 Lakh (FY 2022) | Hyderabad, Telangana, India | ||||
| Piacular Private Limited | ₹2.06 Lakh (FY 2018) | Patna, Bihar, India | ||||
| Voltron Calcium Private Limited | ₹2.05 Lakh (FY 2024) | Dehradun, Uttarakhand, India |
To see the full peer comparison of Innrise Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innrise Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innrise Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innrise Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCI0704M1ZN | Haryana | Active | 17 May 2023 |
To see the full GST registrations and return filing status of Innrise Biotech Private Limited, buy the company report.
Recent activity
Innrise Biotech Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Rashmeet Kaur was appointed as Director on 11 Apr 2023.
Frequently asked questions
Innrise Biotech is an active private limited company based in Ambala, Haryana, India. It was incorporated on 11 April 2023 (3+ years old) and is registered under CIN U46497HR2023PTC110642.
Innrise Biotech has 2 current directors:
- Rashmeet Kaur - Director
- Sarabjeet Singh - Director
The latest financial statements of Innrise Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 December 2024. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Innrise Biotech is 06AAHCI0704M1ZN, registered in Haryana.
The CIN (Corporate Identification Number) of Innrise Biotech is U46497HR2023PTC110642. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innrise Biotech was incorporated on 11 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Innrise Biotech by revenue are Lay Healthcare Private Limited, Yeager Pharmaceuticals Private Limited, Wic-Chem Private Limited, Ravi Ayurved Bhawan Private Limited, Grainery Bio Science Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rashmeet Kaur was appointed as Director on 11 Apr 2023. Sarabjeet Singh was appointed as Director on 11 Apr 2023.
The registered office of Innrise Biotech is at Plot No. 993 & 994 Sethi Enclave Dhulkote, Ambala, Haryana, India – 134003.
Innrise Biotech can be reached at its registered office: Plot No. 993 & 994 Sethi Enclave Dhulkote, Ambala, Haryana, India – 134003.
Innrise Biotech is registered under the jurisdiction of the Registrar of Companies (ROC), Haryana.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
